Results of a small clinical trial show that a vaccine used to treat women with high-grade precancerous cervical lesions triggers an immune cell response within the damaged tissue itself. The Johns Hopkins scientists who conducted the trial said the finding is significant because measuring immune system responses directly in the lesions may be a more accurate way to evaluate so-called "therapeutic" vaccines than by the conventional means of blood analysis. "It's ...
Read MoreYou have just read an article categorized health
titled Vaccine Used to Treat High-Grade Cervical Precancers Triggers Immune Cell Response.
Written by:
editor - Saturday, February 1, 2014
There are currently no comments for "Vaccine Used to Treat High-Grade Cervical Precancers Triggers Immune Cell Response"
Post a Comment